PLUME: A single-arm phase II trial evaluating the combination of pembrolizumab and lenvatinib in metastatic uveal melanoma (mUM) patients (pts) previously treated or not with tebentafusp

被引：0
|
作者：
Rodrigues, Manuel
Saint-Ghislain, Mathilde
Ramtohul, Toulsie
de Koning, Leanne
Bouchez, Clementine
Lafite, Elsa
Ajgal, Zahra Castel
Marret, Gregoire
Sanchez, Raphael
Mariani, Pascale
Nespoulous, Sandra
Gillon, Veronique
Servois, Vincent
Piperno-Neumann, Sophie
机构：
[1] Inst Curie, Med Oncol Dept, Paris, France
[2] Curie Inst, Paris, France
[3] Paris Saclay Univ, Inst Curie, Dept Drug Dev & Innovat, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9613
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
    Chaoyuan Kuang
    Yongseok Park
    Ryan C. Augustin
    Yan Lin
    Douglas J. Hartman
    Lindsey Seigh
    Reetesh K. Pai
    Weijing Sun
    Nathan Bahary
    James Ohr
    John C. Rhee
    Stanley M. Marks
    H. Scott Beasley
    Yongli Shuai
    James G. Herman
    Hassane M. Zarour
    Edward Chu
    James J. Lee
    Anuradha Krishnamurthy
    Clinical Epigenetics, 2022, 14
  • [42] Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
    Kuang, Chaoyuan
    Park, Yongseok
    Augustin, Ryan C.
    Lin, Yan
    Hartman, Douglas J.
    Seigh, Lindsey
    Pai, Reetesh K.
    Sun, Weijing
    Bahary, Nathan
    Ohr, James
    Rhee, John C.
    Marks, Stanley M.
    Beasley, H. Scott
    Shuai, Yongli
    Herman, James G.
    Zarour, Hassane M.
    Chu, Edward
    Lee, James J.
    Krishnamurthy, Anuradha
    CLINICAL EPIGENETICS, 2022, 14 (01)
  • [43] Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring c-Kit Mutation or Amplification
    Guo, Jun
    Si, Lu
    Kong, Yan
    Flaherty, Keith T.
    Xu, Xiaowei
    Zhu, Yanyan
    Corless, Christopher L.
    Li, Li
    Li, Haifu
    Sheng, Xinan
    Cui, Chuanliang
    Chi, Zhihong
    Li, Siming
    Han, Mei
    Mao, Lili
    Lin, Xuede
    Du, Nan
    Zhang, Xiaoshi
    Li, Junling
    Wang, Baocheng
    Qin, Shukui
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (21) : 2904 - 2909
  • [44] A phase II single arm multi-center trial evaluating the efficacy of pembrolizumab in the treatment of patients (pts) with incurable platinum refractory germ cell tumors (GCT)
    Adra, Nabil
    Ammakkanavar, Natraj
    Radovich, Milan
    Vaughn, David J.
    Albany, Costantine
    Einhorn, Lawrence H.
    Hanna, Nasser H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study
    Silk, Ann W.
    O'Day, Steven J.
    Kaufman, Howard L.
    Bryan, Jennifer
    Norrell, Jacqueline T.
    Imbergamo, Casey
    Portal, Daniella
    Zambrano-Acosta, Edwin
    Palmeri, Marisa
    Fein, Seymour
    Wu, Cai
    Guerreiro, Leslie
    Medina, Daniel
    Bommareddy, Praveen K.
    Zloza, Andrew
    Fox, Bernard A.
    Ballesteros-Merino, Carmen
    Ren, Yixin
    Shafren, Darren
    Grose, Mark
    Vieth, Joshua A.
    Mehnert, Janice M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (06) : 1405 - 1415
  • [46] A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study
    Ann W. Silk
    Steven J. O’Day
    Howard L. Kaufman
    Jennifer Bryan
    Jacqueline T. Norrell
    Casey Imbergamo
    Daniella Portal
    Edwin Zambrano-Acosta
    Marisa Palmeri
    Seymour Fein
    Cai Wu
    Leslie Guerreiro
    Daniel Medina
    Praveen K. Bommareddy
    Andrew Zloza
    Bernard A. Fox
    Carmen Ballesteros-Merino
    Yixin Ren
    Darren Shafren
    Mark Grose
    Joshua A. Vieth
    Janice M. Mehnert
    Cancer Immunology, Immunotherapy, 2023, 72 : 1405 - 1415
  • [47] Phase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962)
    Piulats Rodriguez, M.
    de la Cruz-Merino, L.
    Espinosa, E.
    Alonso Carrion, L.
    Martin Algarra, S.
    Lopez-Castro, R.
    Curiel Garcia, M. T.
    Rodriguez Abreu, D.
    Rullan Iriarte, A. J.
    Berrocal Jaime, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 444 - 444
  • [48] Phase Ib/II study of ibrutinib (ibr) in combination with cetuximab (cetux) in patients (pts) with previously treated metastatic colorectal cancer (mCRC)
    Oh, D-Y.
    Arkenau, T.
    Lee, K-W.
    Alsina, M.
    Marti, F. M.
    Chung, I. J.
    Saif, W.
    Wang, D.
    O'Dwyer, P.
    Chau, I.
    Lee, M-A.
    Chong, E.
    Hilger-Rolfe, J.
    Cole, G., Jr.
    Kim, S. Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S428 - S428
  • [49] Antitumor activity of bintrafusp alfa in previously treated patients with recurrent or metastatic nasopharyngeal cancer (NPC): A single arm, prospective phase II trial.
    Chiang, Chi Leung
    Lam, Tai Chung
    Li, Chung Bong James
    Li, Wing Sum
    Chan, Sik-Kwan
    Lee, Yim Ping Yolanda
    Cheung, Ka Wai Alice
    Chow, James Chung Hang
    Chan, Po Chung Sunny
    Man, Wai
    Lee, Sarah
    Lai, Wing Yu Jessica
    El Helali, Aya
    Ng, Wai-Tong
    Kong, Feng-Ming Spring
    Kwong, Dora L. W.
    Lee, Wing Mui Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18029 - E18029
  • [50] Efficacy and safety of utidelone in previously treated patients with advanced or metastatic soft tissue sarcomas (HX-SARC02): A prospective, single-arm, phase II study
    Jiang, Y.
    Fu, Y.
    Liu, J.
    Wang, B.
    Li, M.
    Zhang, H.
    Deng, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S1046 - S1046
12345